Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

NCT04159961 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DWJ211

Sponsor

Daewoong Pharmaceutical Co. LTD.